Newsletter | July 1, 2025

07.01.25 -- STREAM Edition: De-Risk Your Path To Clinic With An AAV Suspension Platform

De-Risk Your Path To Clinic With An AAV Suspension Platform

Webinar | Lonza

Build a reliable, de-risked path to the clinic while avoiding unforeseen costs and compliance-related delays with advice from Suparna Sanyal, PhD, Head of Viral Vectors Commercial Development.

How Early Automation Strategies Reduce Costs And Improve Patient Access

Video | Ori Biotech

A pioneer in regenerative medicine reveals how to bridge the gap from research to reality. Learn how early automation and strategic partnerships can slash costs and expand patient access to therapies.

Reducing Costs Via Automated And Closed Systems

Video | Cytiva

By embracing these advanced technologies, learn how you can streamline your operations, enhance accuracy, and mitigate risks effectively.

Key Considerations For Automating A Cell Therapy Manufacturing Program

Webinar | Invetech

Delve into the dynamic transition towards automation in cell and gene therapy manufacturing as well as the challenges it presents to start ups with industry experts in this webinar.

Freezing Studies For Single-Use Solutions

Video | Charter Medical

Learn about the four common types of cryogenic studies for advanced therapies: controlled-rate, long-term, therapy containment/protection, and transportation.

Extracellular Vesicle Breakthroughs with Aegle Therapeutics' Dr. Gloria Matthews

Video | Cell & Gene

In this episode of Cell & Gene: The Podcast, Host Erin Harris interviews Dr. Gloria Matthews, Chief Medical Officer of Aegle Therapeutics, a clinical-stage regenerative medicine company focused on developing therapies for rare and severe dermatologic and immunologic disorders.